OP-1118
CAS: 1030825-28-5
Ref. 3D-FO71470
1mg | 300.00 € | ||
2mg | 422.00 € | ||
5mg | 704.00 € | ||
10mg | 1,218.00 € | ||
25mg | 2,609.00 € |
Product Information
- Fidaxomicin-Met
OP-1118 is a small molecule that inhibits the activity of NF-κB, which is a major regulator of inflammatory responses. It has been shown to have an inhibitory effect on intestinal inflammation and infectious diseases. OP-1118 also has bactericidal properties and can be used in conjunction with antibiotics to treat bacterial infections. This drug is currently undergoing clinical development as a potential treatment for inflammatory bowel disease. Animal studies have shown that OP-1118 has little effect on the gut flora, which may be due to its low plasma concentrations.
Chemical properties
Technical inquiry about: 3D-FO71470 OP-1118
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.